HONG Zhongsi,DONG Wenxiao,DUAN Siyu,et al.Observation and analysis of traditional Chinese medicine syndrome distribution in children with different Omicron mutant subtypes[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(12):1437-1440.
HONG Zhongsi,DONG Wenxiao,DUAN Siyu,et al.Observation and analysis of traditional Chinese medicine syndrome distribution in children with different Omicron mutant subtypes[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(12):1437-1440. DOI: 10.16025/j.1674-1307.2024.12.023.
Observation and analysis of traditional Chinese medicine syndrome distribution in children with different Omicron mutant subtypes
TAKASHITA E, YAMAYOSHI S, SIMON V, et al. Efficacy of antibodies and antiviral drugs against Omicron BA.2.12.1, BA.4, and BA.5 sub-variants[J]. N Engl J Med, 2022,387(5):468-470.
TEGALLY H, MOIR M, EVERATT, et al. Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa[J]. Nat Med, 2022,28(9):1785-1790.
TANNE JH. Covid-19: BA.5 variant is now dominant in US as infections rise[J]. BMJ (Clinical research ed), 2022,378:o1770.
CALLAWAY E. What Omicron's BA.4 and BA.5 variants mean for the pandemic[J]. Nature, 2022,606(7916):848-849.
JU BIN, ZHANG QI, GE JIWAN, et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection[J]. Nature, 2020,584(7819):115-119.
ARORA P, KEMPF A, NEHLMEIER I, et al. Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5[J]. Lancet Infect Dis, 2022,22(8):1117-1118.
ZHANG HT, HUANG MX, LIU X, et al. Evaluation of the adjuvant efficacy of natural herbal medicine on COVID-19: A retrospective matched case-control study[J]. Am J Chin Med, 2020,48(4):779-792.
Disease-syndrome patterns of pulmonary hypertension associated with interstitial lung disease based on complex networks and latent structure models
Value of blood gas indexes on identification of TCM syndromes in acute exacerbation of chronic obstructive pulmonary disease
Retrospective analysis on TCM syndrome characteristics of 33 patients with pulmonary sarcoidosis
Characteristics of TCM syndrome distribution in patients with metabolic-related fatty liver disease and its correlation with clinical biochemical parameters
Literature study on TCM syndrome distribution and TCM medication law of pulmonary hypertension